Steroids In Eosinophil Negative Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

295

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Asthma
Interventions
DRUG

Mometasone 220mcg BID

Mometasone is an ICS

DRUG

Tiotropium Respimat 5mcg QD

Tiotropium is a LMA

DRUG

Placebo

Trial Locations (25)

10032

Columbia University Medical Center, New York

15212

Allegheny General Hospital, Pittsburgh

15213

University of Pittsburgh, Pittsburgh

15224

Children's Hospital of Pittsburgh of UPMC, Pittsburgh

27110

Duke University School of Medicine, Durham

27157

Wake Forest University Health Sciences, Winston-Salem

27607

North Carolina Clinical Research, Raleigh

30322

Emory University, Atlanta

32207

Nemours Children's Clinic, Jacksonville

32827

Nemours Children's Clinic, Orlando

44106

Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland

53792

University of Wisconsin-Madison, Madison

60611

Northwestern Memorial Hospital, Chicago

60612

Rush University Medical Center, Chicago

University of Illinois at Chicago, Chicago

60614

Ann and Robert H. Lurie Children's Hospital, Chicago

60637

University of Chicago, Chicago

63110

St. Louis Children's Hospital, St Louis

Washington University, St Louis

80206

National Jewish Health, Denver

85724

University of Arizona College of Medicine, Tucson

94143

UCSF Benioff Children's Hospital, San Francisco

University of California at San Francisco, San Francisco

02115

Brigham and Women's Hospital, Boston

Children's Hospital Boston, Boston

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Milton S. Hershey Medical Center

OTHER

NCT02066298 - Steroids In Eosinophil Negative Asthma | Biotech Hunter | Biotech Hunter